Association between vitamin D receptor gene FokI polymorphism and mortality in patients with sepsis
Background Sepsis is life-threatening organ dysfunction as a result of the host’s dysregulated immune response to infection. The vitamin D receptor ( VDR ) gene FokI polymorphism influences immune cell behavior. In the present study, we aimed to investigate the association between VDR FokI polymorph...
Gespeichert in:
Veröffentlicht in: | Molecular biology reports 2024-12, Vol.51 (1), p.44-44, Article 44 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Sepsis is life-threatening organ dysfunction as a result of the host’s dysregulated immune response to infection. The
vitamin D receptor
(
VDR
) gene
FokI
polymorphism influences immune cell behavior. In the present study, we aimed to investigate the association between
VDR FokI
polymorphism and mortality in sepsis and non-sepsis patients in the intensive care unit (ICU).
Methods and results
This is a prospective observational study involving 96 sepsis and 96 non-sepsis patients admitted to the Ege University ICU.
VDR FokI
polymorphisms were investigated, as well as the relationship between the identified polymorphisms and mortality.
In-hospital mortality was 27.1% in the sepsis group and 8.33% in the non-sepsis group (p = 0.001). The frequencies of VDR FokI TT, TC, and CC genotypes were 8 (8.33%), 48 (50.0%), and 40 (41.7%) in the sepsis group, and 11 (11.5%), 42 (43.8%), and 43 (44.8%) in the non-sepsis group, respectively (p = 0.612). In the sepsis group, the frequencies of Fokl TT, TC, and CC genotypes did not differ significantly between survivors and non-survivors. However, homozygous C allele carriers had lower overall mortality (p = 0.047).
Conclusion
The
VDR FokI
polymorphism, particularly the CC genotype, appears to be associated with lower mortality in ICU patients. |
---|---|
ISSN: | 0301-4851 1573-4978 |
DOI: | 10.1007/s11033-023-08971-8 |